Evidence mapPaperPMID 37288470Full record

ArticleStatistical communications in infectious diseases2020

Pre-selected class-level testing of longitudinal biomarkers reduces required multiple testing corrections to yield novel insights in longitudinal small sample human studies.

Andrea S Foulkes, Livio Azzoni, Luis J Montaner

Open access · greenAbstract read
In one paragraph

Article in Statistical communications in infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Andrea S FoulkesBiostatistics Center, Massachusetts General Hospital, Boston, USA.
Livio AzzoniWistar Institute, Philadelphia, USA.
Luis J MontanerWistar Institute, Philadelphia, USA.
The Wistar Institute · USHarvard University · US

Funding

Virus & Reservoirs CoreP30AI045008 · UNIVERSITY OF PENNSYLVANIA · 1999 to 2025
$13.1M
Methods for integrated analysis of multi-level omics dataR01GM127862 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI Andrea S Foulkes · 2022 to 2022
$418k
NIAID NIH HHS P30 AI045008NIAID NIH HHS UM1 AI126620NIDDK NIH HHS U01 DK103225NIGMS NIH HHS R01 GM127862
6 · The paper itself

Abstract

Objectives: Exploratory studies that aim to evaluate novel therapeutic strategies in human cohorts often involve the collection of hundreds of variables measured over time on a small sample of individuals. Stringent error control for testing hypotheses in this setting renders it difficult to identify statistically signification associations. The objective of this study is to demonstrate how leveraging prior information about the biological relationships among variables can increase power for novel discovery. Methods: We apply the class level association score statistic for longitudinal data (CLASS-LD) as an analysis strategy that complements single variable tests. An example is presented that aims to evaluate the relationships among 14 T-cell and monocyte activation variables measured with CD4 T-cell count over three time points after antiretroviral therapy (n=62). Results: CLASS-LD using three classes with emphasis on T-cell activation with either classical vs. intermediate/inflammatory monocyte subsets detected associations in two of three classes, while single variable testing detected only one out of the 14 variables considered. Conclusions: Application of a class-level testing strategy provides an alternative to single immune variables by defining hypotheses based on a collection of variables that share a known underlying biological relationship. Broader use of class-level analysis is expected to increase the available information that can be derived from limited sample clinical studies.

Indexed as

biomarker analysisCD4 recoveryclustered data methodslongitudinal datamultiple testing adjustments

Identifiers

PMID37288470
PMCPMC10243175
OpenAlexW3112272781

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.